default author photo

Liang Ye

Binzhou Medical University

Yantai, Laishan, Gangcheng E St

Shandong

China

SCHOLARLY PAPERS

2

DOWNLOADS

166

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Discovery of Novel, Potent Polo-Like Kinase 1 (PLK1) Inhibitors for the Treatment of Colorectal Cancer

Number of pages: 30 Posted: 03 Feb 2023
Yantai University, R & D Center, Luye Pharma Group Ltd., R & D Center, Luye Pharma Group Ltd., Yantai University, Yantai University, Yantai University, Yantai University, Yantai University, Yantai University, R & D Center, Luye Pharma Group Ltd., R & D Center, Luye Pharma Group Ltd., Yantai University, Binzhou Medical University, Yantai University, Yantai University and Yantai University
Downloads 86 (783,685)

Abstract:

Loading...

colorectal cancer, PLK1 inhibitor, Core scaffold hopping, structure-activity relationship

2.

A Novel Scaffold Long-Acting Selective Estrogen Receptor Antagonist and Degrader with Superior Preclinical Profile Against Er+ Breast Cancer

Number of pages: 49 Posted: 05 Sep 2023
Yantai University, Yantai University, Luye Pharma Group Ltd., Binzhou Medical University, Binzhou Medical University, Yantai University, Luye Pharma Group Ltd., Luye Pharma Group Ltd., Luye Pharma Group Ltd., Luye Pharma Group Ltd., Luye Pharma Group Ltd., Luye Pharma Group Ltd., Shandong University - School of Business, Yantai University - Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong and Yantai University - Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University)
Downloads 80 (809,932)
Citation 1

Abstract:

Loading...

Hydrophobic tags, THC derivatives, Selective estrogen receptor down-regulator/antagonist, Long-acting, Anticancer agents, breast cancer